XML 25 R107.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Parent Company Information - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities                      
Net income (loss) $ 3.1 $ 11.7 $ 6.3 $ (20.9) $ (18.0) $ (41.4) $ (33.5) $ (92.9) $ 0.2 $ (185.8) $ (221.3)
Reconciliation of net income (loss) to net cash used in operating activities:                      
Unrealized foreign exchange gain                 (5.9) 5.6 (2.6)
Trade and other receivables                 (38.9) (235.5) (173.4)
Increase in other liabilities                 (164.8) (216.8) 58.8
Net cash (used in) provided by operating activities                 269.3 (2.2) 4.4
Cash flows from investing activities:                      
Net cash used in investing activities                 (274.9) (218.0) (143.2)
Cash flows from financing activities:                      
Proceeds from issuance of common stock                 0.3 9.0 23.4
Proceeds from initial public offering, net of underwriting                 0.0 831.4 0.0
Proceeds from private placement                 0.0 179.5 0.0
Payments of initial offering and private placement costs                 0.0 (17.3) 0.0
Other financing activities, net                 (2.3) (7.3) 2.3
Net cash (used in) provided by financing activities                 (89.6) 725.9 167.7
Change in cash, cash equivalents and restricted cash                 (95.2) 505.7 28.9
Cash, cash equivalents and restricted cash, beginning of the year       965.4       467.9 965.4 467.9 424.8
Cash, cash equivalents and restricted cash, end of the year 872.3       965.4       872.3 965.4 467.9
Supplemental disclosure of non-cash activities:                      
Stock-based compensation                 61.3 81.9 52.4
Cushman & Wakefield plc                      
Cash flows from operating activities                      
Net income (loss)                 0.2 (185.8) (221.3)
Reconciliation of net income (loss) to net cash used in operating activities:                      
(Income) loss in earnings of subsidiaries                 (0.4) 170.5 215.5
Unrealized foreign exchange gain                 0.0 0.0 0.0
Trade and other receivables                 0.0 (128.7) 0.0
Increase in trade and other payables                 0.0 20.0 0.5
Increase in other liabilities                 0.0 6.2 5.8
Net cash (used in) provided by operating activities                 (0.2) (117.8) 0.5
Cash flows from investing activities:                      
Investment in subsidiaries                 0.0 (865.5) (22.5)
Net cash used in investing activities                 0.0 (865.5) (22.5)
Cash flows from financing activities:                      
Proceeds from issuance of common stock                 0.3 0.0 22.0
Proceeds from initial public offering, net of underwriting                 0.0 831.4 0.0
Proceeds from private placement                 0.0 179.5 0.0
Payments of initial offering and private placement costs                 0.0 (17.3) 0.0
Other financing activities, net                 0.1 0.2 0.0
Net cash (used in) provided by financing activities                 0.4 993.8 22.0
Change in cash, cash equivalents and restricted cash                 0.2 10.5 0.0
Cash, cash equivalents and restricted cash, beginning of the year       $ 10.5       $ 0.0 10.5 0.0 0.0
Cash, cash equivalents and restricted cash, end of the year $ 10.7       $ 10.5       10.7 10.5 0.0
Supplemental disclosure of non-cash activities:                      
Accretion of deferred purchase obligation                 0.0 19.7 20.8
Capital contributions to subsidiaries                 0.0 0.0 6.2
Stock-based compensation                 61.3 51.4 43.3
Acquisition and disposal of non-controlling interest                 $ 0.0 $ 0.0 $ 2.0